Adynovate recombinant and Disopyramide Sustained-Release Capsules
Determining the interaction of Adynovate recombinant and Disopyramide Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-DisperMox
- Adynovate recombinant-Disposable Enema rectal
- Adynovate recombinant-Disulfiram
- Adynovate recombinant-Dithol Solution
- Adynovate recombinant-Ditropan
- Adynovate recombinant-Ditropan XL
- Disopyramide Sustained-Release Capsules-Adzenys ER
- Disopyramide Sustained-Release Capsules-Adzenys ER Oral Suspension
- Disopyramide Sustained-Release Capsules-Adzenys XR-ODT
- Disopyramide Sustained-Release Capsules-Aemcolo
- Disopyramide Sustained-Release Capsules-Aerobid
- Disopyramide Sustained-Release Capsules-Aerobid-M